#psychedelics #ScienceMatters
In recent years, psychedelic drugs like psilocybin, LSD, and MDMA have experienced a surge of interest from researchers, pharmaceutical companies, and the media. Touted as potential breakthrough treatments for conditions ranging from depression to addiction, psychedelics have captured the public imagination and garnered significant investment. However, a closer examination of the scientific evidence reveals concerning flaws in much of the existing research, leading to growing scepticism about the therapeutic potential of these substances. (Source: August 2024 WRD News)